𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Autologous Stem Cell Transplantation as Front Line Therapy Does Not Improve the Outcome of High Risk Aggressive Non-Hodgkin'S Lymphoma: A Single Center Study

✍ Scribed by J.-H. Won; J. Yun; H.J. Kim; K.H. Kim; S.-H. Kim; S.-C. Lee; H.J. Kim; S.B. Bae; C.K. Kim; N.S. Lee; K.-T. Lee; S.K. Park; D.S. Hong; H.S. Park

Book ID
116282243
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
48 KB
Volume
17
Category
Article
ISSN
1083-8791

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose therapy and autologous stem ce
High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325
📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB